121 related articles for article (PubMed ID: 6991941)
1. Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.
Woods RL; Fox RM; Tattersall MH; Levi JA; Brodie GN
N Engl J Med; 1980 Jul; 303(2):87-9. PubMed ID: 6991941
[No Abstract] [Full Text] [Related]
2. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
Oster MW
Cancer Treat Rep; 1979 Aug; 63(8):1417-8. PubMed ID: 476715
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
6. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
7. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
[TBL] [Abstract][Full Text] [Related]
8. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
Livingston RB; Mira J; O'Bryan RM
Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.
Fraile RJ; Samson MK; Baker LH; Talley RW
Cancer Treat Rep; 1979; 63(11-12):1983-7. PubMed ID: 230896
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study.
Shildt RA; Kennedy PS; Chen TT; Athens JW; O'Bryan RM; Balcerzak SP
Cancer Treat Rep; 1983 Jan; 67(1):77-9. PubMed ID: 6616495
[TBL] [Abstract][Full Text] [Related]
11. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
[TBL] [Abstract][Full Text] [Related]
12. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for advanced pancreatic carcinoma.
Costanzi JJ; Panettiere FJ; Wolma FJ
Tex Med; 1979 Sep; 75(9):50-1. PubMed ID: 494115
[No Abstract] [Full Text] [Related]
15. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
Davis S; Park YK
Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
17. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
[TBL] [Abstract][Full Text] [Related]
20. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
